Paul Eynott is CEO of Acudora, Inc. Acudora creates revolutionary technology that enhances digital sound to match customers’ “Acoustic DNA,” or unique hearing signature, and aims to transform listening on digital devices and change communications on a global scale. Paul holds faculty appointments at the University of Arizona’s College of Pharmacy and Department of Physiology, and is on the Dean’s Advisory Boards for both the College of Engineering and the College of Science. He received a doctorate in pharmacology from Imperial College London, where he completed post-doctoral assignments. Paul received his B.S. in pharmacology from the University of Manchester. He is a published scientist and a regular panelist on discussions about innovation and commercialization of early stage assets.
